Results 101 to 110 of about 18,976 (183)

Diffuse Pleural Mesothelioma Initially Presenting as Cervical Lymphadenopathy: A Report of a Rare Case. [PDF]

Cureus
Saha K, Ghosh S, Poddar S.
europepmc   +1 more source

Immunotherapy advances in pleural mesothelioma. [PDF]

Ther Adv Med Oncol
Zhang AL, Hsu ML.
europepmc   +1 more source

Prognostic Significance of B7-H3, TROP2, and p16 Expression in Pleural Mesothelioma: Clinicopathological Correlations and Survival Outcomes. [PDF]

J Clin Med
Tas N, Yüceer RO, Koc T, Sönmez Y, Dogan H.   +4 more
europepmc   +1 more source

BAP1 Loss Might Be a Predictive Biomarker for Immunotherapy Response in Pleural Mesothelioma. [PDF]

Thorac Cancer
Imase R, Sakakibara R, Kirimura S, Ishibashi H, Okubo K, Miyazaki Y.   +5 more
europepmc   +1 more source

Pseudo-Meigs'syndrome mimicking malignant pleural mesothelioma: a case report and diagnostic pitfall analysis. [PDF]

Front Med (Lausanne)
Sheng H, Zong W, Song Z, Yu Q.
europepmc   +1 more source

Haemophagocytic Lymphohistiocytosis Following Ipilimumab and Nivolumab in Malignant Pleural Mesothelioma: A Case Report. [PDF]

Cureus
Than CM, Moe M, Win Y, Maung K.
europepmc   +1 more source

Trop-2 expression is associated with poor survival in pleural mesothelioma. [PDF]

Front Oncol
Aviles-Salas A, Hernández-Pedro N, Caballé-Perez E, Lucio-Lozada J, Castillo-Ruiz C, Chanona-Vilchis JG, Aranda-Gutierrez A, Orozco-Morales M, Barrios-Bernal P, Parra-Medina R, Cabrera-Miranda L, Cardona AF, Arrieta O.   +12 more
europepmc   +1 more source

Correction to 'Cul4A is an oncogene in malignant pleural mesothelioma'. [PDF]

J Cell Mol Med
europepmc   +1 more source

Radiofrequency Ablation for Recurrent Pleural Mesothelioma. [PDF]

Cancers (Basel)
Kodama H, Kuribayashi K, Takaki H, Matsuda K, Shinkai T, Wada R, Ogasawara A, Hashimoto M, Fujimoto D, Minami T, Funaki S, Kijima T, Yamakado K.   +12 more
europepmc   +1 more source

Proliferation of pleural mesothelioma cells is enhanced by the microRNA-197-3p activity. [PDF]

Front Oncol
Bononi I, Di Mauro G, Tramarin ML, Esposito V, Tonnini G, Oton-Gonzalez L, Dallan B, Torreggiani E, Martini F, Tognon M.   +9 more
europepmc   +1 more source